Le Lézard
Classified in: Health, Business
Subject: JVN

Medical Facilities Corporation Announces Sale of Ambulatory Surgery Center


TORONTO, Oct. 1, 2020 /CNW/ - Medical Facilities Corporation (TSX: DR) ("Medical Facilities" or the "Company") today announced a definitive agreement to sell its interest in Two Rivers Surgical Center to two of the managing physicians for an undisclosed amount. Medical Facilities acquired interest in this ambulatory surgery center ("ASC") through a joint venture with NueHealth, LLC in early 2018.

"The sale of our interest in Two Rivers Surgical Center allows us to focus our attention and capital on our current strategic initiatives," said Robert Horrar, President and CEO of Medical Facilities. "The overall direction of this ASC had changed considerably since our initial investment and we believe our focus should be directed at other growth opportunities we see in the ASC space, including de novo ASC development, like the recently opened St. Luke's Surgery Center of Chesterfield."

About Medical Facilities

Medical Facilities Corporation ("MFC"), in partnership with physicians, owns a diverse portfolio of highly rated, high-quality surgical facilities in the United States. MFC's ownership includes controlling interest in four specialty surgical hospitals located in Arkansas, Oklahoma, and South Dakota, and an ambulatory surgery center ("ASC") located in California. In addition, through a partnership with NueHealth LLC, Medical Facilities owns controlling interest in five ambulatory surgery centers located in Michigan, Missouri, Nebraska, Ohio, and Pennsylvania. MFC also owns non-controlling interests in a specialty surgical hospital in Indiana and an ASC in Missouri. The specialty surgical hospitals perform scheduled surgical, imaging, diagnostic and other procedures, including primary and urgent care, and derive their revenue from the fees charged for the use of their facilities. The ASCs specialize in outpatient surgical procedures, with patient stays of less than 24 hours. For more information, please visit www.medicalfacilitiescorp.ca.

Caution concerning forward-looking statements
Statements made in this news release, other than those concerning historical financial information, may be forward-looking and therefore subject to various risks and uncertainties.  Some forward-looking statements may be identified by words like "may", "will", "anticipate", "estimate", "expect", "intend", or "continue" or the negative thereof or similar variations.  Certain material factors or assumptions are applied in making forward-looking statements and actual results may differ materially from those expressed or implied in such statements.  Factors that could cause results to vary include those identified in Medical Facilities' filings with Canadian securities regulatory authorities such as legislative or regulatory developments, intensifying competition, technological change and general economic conditions.  All forward-looking statements presented herein should be considered in conjunction with such filings.  Medical Facilities does not undertake to update any forward-looking statements; such statements speak only as of the date made.

SOURCE Medical Facilities Corporation


These press releases may also interest you

at 08:30
Alto Neuroscience, Inc. ("Alto") today announced positive results from its healthy volunteer Phase 1 study of ALTO-101, a novel PDE4 inhibitor in development for cognitive impairment associated with schizophrenia (CIAS). Results from the study...

at 08:30
Hera Biotech is pleased to report the interim results for its proof-of-concept multi-center clinical trial of the MetriDxtm endometriosis diagnostic test. Per protocol data from the first 38 patients who have been enrolled in the 60 patient study...

at 08:25
Dyno Therapeutics, Inc., a techbio company pioneering applications of artificial intelligence to engineer AAV capsids that expand the potential of genetic medicine, today announced a Scientific Symposium and the presentation of three research...

at 08:20
Optimi Health Corp. (FRA: 8BN), a leading Health Canada licensed psychedelics pharmaceutical manufacturer, is thrilled to announce an innovative research and development partnership with the Kwantlen Polytechnic University Applied Genomics Centre...

at 08:20
Zepp Health Corporation ("Zepp" or the "Company") today announced that it has filed its annual report on Form 20-F for the full year ended December 31, 2023 with the U.S. Securities and Exchange Commission (the "SEC"). The annual report can be...

at 08:17
IBEX IT Business Experts, LLC (IBEX), a leading provider of technology, training, and staffing services announces the receipt of the U.S. Department of Health and Human Services (HHS) Office of Small and Disadvantaged Business Utilization (OSDBU)...



News published on and distributed by: